TY  - GEN
AU  - Ricceri,F
AU  - Pescitelli,L
AU  - Lazzeri,L
AU  - Di Cesare,A
AU  - Prignano,F
TI  - Reply: adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature
SN  - 1468-3083
PY  - 2019///0513
KW  - Adalimumab
KW  - Cohort Studies
KW  - Hepatitis B
KW  - Humans
KW  - Psoriasis
N1  - Publication Type: Letter; Comment
UR  - https://doi.org/10.1111/jdv.14300
ER  -